Drug
Berobenatide
Berobenatide: highest development phase Phase 3, developed by Pfizer. 5 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Berobenatide NCT07794774 | Phase 3 | Obesity |
| Berobenatide NCT07874633 | Phase 3 | Obesity |
| Berobenatide NCT07919678 | Phase 3 | Obesity |
| Berobenatide NCT07881757 | Phase 3 | Apnea |
| Berobenatide NCT07876531 | Phase 1 | Overweight and/or Obesity |
Latest
No recent events.
Follow Berobenatide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.